Trade Summary

2 days ago, Shields Matthew, serving as EVP, Global Operations at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 16,195 shares at $32.87 per share, for a total transaction value of $532,329.65. Following this transaction, Shields Matthew now holds 9,989 shares of TEVA.

This sale represents a 61.85% decrease in Shields Matthew's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 3, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 4, 2026 at 4:00 PM ET, 1 day after the trade was made.

TEVA PHARMACEUTICAL INDUSTRIES LTD operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.